HBM Healthcare Investments AG Stock price

Equities

HBMN

CH0012627250

Investment Management & Fund Operators

Market Closed - Swiss Exchange 12:31:47 2024-03-18 pm EDT 5-day change 1st Jan Change
186.8 CHF -2.20% Intraday chart for HBM Healthcare Investments AG -0.53% +2.30%
Sales 2024 * -42.4M -47.69M Sales 2025 * 46.1M 51.85M Capitalization 1.29B 1.45B
Net income 2024 * -71M -79.86M Net income 2025 * 18M 20.25M EV / Sales 2024 * -29.7 x
Net cash position 2024 * 32M 35.99M Net cash position 2025 * 53M 59.61M EV / Sales 2025 * 26.9 x
P/E ratio 2024 *
-18 x
P/E ratio 2025 *
77.2 x
Employees 700
Yield 2024 *
4.01%
Yield 2025 *
3.01%
Free-Float 82.87%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.20%
1 week-0.53%
Current month+3.78%
1 month+15.17%
3 months+7.60%
6 months+3.43%
Current year+2.30%
More quotes
1 week
186.00
Extreme 186
193.80
1 month
168.00
Extreme 168
194.60
Current year
155.00
Extreme 155
194.60
1 year
135.20
Extreme 135.2
225.00
3 years
135.20
Extreme 135.2
367.00
5 years
135.20
Extreme 135.2
367.00
10 years
70.25
Extreme 70.25
367.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 01-06-30
Director of Finance/CFO 53 11-10-31
Corporate Secretary 60 -
Members of the board TitleAgeSince
Chairman 68 09-05-31
Director/Board Member 69 21-06-17
Director/Board Member 52 11-12-31
More insiders
Date Price Change Volume
24-03-18 186.8 -2.20% 5,332
24-03-15 191 -0.31% 9,778
24-03-14 191.6 +0.84% 9,061
24-03-13 190 -0.94% 6,075
24-03-12 191.8 +2.13% 5,018

Delayed Quote Swiss Exchange, March 18, 2024 at 12:31 pm EDT

More quotes
HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
186.8 CHF
Average target price
236 CHF
Spread / Average Target
+26.34%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock HBM Healthcare Investments AG - Swiss Exchange